Neumora Therapeutics, Inc. (NMRA) community

NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30

$0.43−0.04 (-8.46%)

Close on Nov 12, 2026Market cap $81.36MP/E –Yield –

Community

Notes and questions about Neumora Therapeutics from other investors

No posts about NMRA yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

See a number that looks wrong?